Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Glecirasib
2. Kras G12c Inhibitor 62
3. Glecirasib [inn]
4. Up75wh4qkm
5. Schembl23830094
6. Ex-a8185q
7. Hy-143589
8. Hy-157067
9. Cs-0373885
10. Cs-0904896
11. 2657613-87-9
12. 2658588-10-2
| Molecular Weight | 640.0 g/mol |
|---|---|
| Molecular Formula | C31H26ClF4N7O2 |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 119 |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 1240 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
73
PharmaCompass offers a list of Glecirasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glecirasib manufacturer or Glecirasib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glecirasib manufacturer or Glecirasib supplier.
PharmaCompass also assists you with knowing the Glecirasib API Price utilized in the formulation of products. Glecirasib API Price is not always fixed or binding as the Glecirasib Price is obtained through a variety of data sources. The Glecirasib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glecirasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glecirasib, including repackagers and relabelers. The FDA regulates Glecirasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glecirasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glecirasib supplier is an individual or a company that provides Glecirasib active pharmaceutical ingredient (API) or Glecirasib finished formulations upon request. The Glecirasib suppliers may include Glecirasib API manufacturers, exporters, distributors and traders.
Glecirasib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glecirasib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glecirasib GMP manufacturer or Glecirasib GMP API supplier for your needs.
A Glecirasib CoA (Certificate of Analysis) is a formal document that attests to Glecirasib's compliance with Glecirasib specifications and serves as a tool for batch-level quality control.
Glecirasib CoA mostly includes findings from lab analyses of a specific batch. For each Glecirasib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glecirasib may be tested according to a variety of international standards, such as European Pharmacopoeia (Glecirasib EP), Glecirasib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glecirasib USP).
